Effectiveness of kumquat decoction for the improvement of cough caused by SARS-CoV-2 Omicron variants, a multicentre, prospective observational study

医学 汤剂 四分位间距 观察研究 内科学 2019年冠状病毒病(COVID-19) 前瞻性队列研究 传统医学 疾病 传染病(医学专业)
作者
Qiaoli Hua,Lijuan Tang,Jingwei Shui,Yuntao Liu,Ge Zhang,Xiaohua Xu,Chunyuan Yang,Wenjian Gao,Guocheng Liao,Qingming Liu,Huilin Liang,Qingkun Mo,Fangxiu Liang,Jianwen Guo,Zhongde Zhang
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:120: 155008-155008 被引量:1
标识
DOI:10.1016/j.phymed.2023.155008
摘要

Kumquat decoction is a traditional Chinese medicine formula and has been widely used to alleviate the coronavirus disease 2019 (COVID-19)-related cough in China. However, the effectiveness and safety of kumquat decoction remain unclear. To assess the effectiveness and safety of kumquat decoction for COVID-19-related cough. A multicentre, prospective observational study. We enrolled consecutive patients with mild-to-moderate COVID-19 from December 31, 2022, to January 3, 2023, during the Omicron phase in Yangshuo County, China. The primary outcome was the time from study baseline to sustained cough resolution by the last follow-up day on January 31, 2023. The effectiveness was evaluated by Cox proportional hazards models based on propensity score analyses. The secondary outcomes were the resolution of cough and other COVID-19-related symptoms by Days 3, 5, and 7. Of 1434 patients, 671 patients were excluded from the analysis of cough resolution. Among the remaining 763 patients, 481 (63.04%) received kumquat decoction, and 282 (36.96%) received usual care. The median age was 38.0 (interquartile range [IQR] 29.0, 50.0) years, and 55.7% were women. During a median follow-up of 7.000 days, 68.2% of patients in the kumquat group achieved sustained cough resolution (93.77 per 1000 person-days) compared to 39.7% in the usual care group (72.94 per 1000 person-days). The differences in restricted mean survival time (RMST) (kumquat decoction minus usual care group) for cough resolution were -0.742 days (95% CI, -1.235 to -0.250, P = 0.003) on Day 7. In the main analysis using propensity-score matching, the adjusted hazard ratio (HR) for cough resolution (kumquat decoction vs. usual care group) was 1.94 (95% CI, 1.48 to 2.53, P < 0.001). Similar findings were found in multiple sensitivity analyses. In addition, the use of kumquat decoction was associated with the resolution of cough, and a stuffy nose on Days 5 and 7, as well as the resolution of sore throat on Day 7 following medication. In this study among patients with COVID-19-related cough, receiving kumquat decoction was associated with an earlier resolution of cough symptoms.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搜集达人应助科研通管家采纳,获得10
刚刚
刚刚
烟花应助科研通管家采纳,获得10
刚刚
李爱国应助科研通管家采纳,获得10
刚刚
哈哈哈应助科研通管家采纳,获得10
刚刚
大个应助科研通管家采纳,获得10
刚刚
大模型应助科研通管家采纳,获得10
刚刚
CipherSage应助科研通管家采纳,获得10
刚刚
Jasper应助科研通管家采纳,获得10
刚刚
研友_VZG7GZ应助科研通管家采纳,获得10
刚刚
刚刚
刚刚
科目三应助科研通管家采纳,获得10
1秒前
1秒前
华仔应助科研通管家采纳,获得10
1秒前
1秒前
香蕉觅云应助科研通管家采纳,获得10
1秒前
1秒前
隐形曼青应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
1秒前
喷火娃应助科研通管家采纳,获得20
1秒前
1秒前
8R60d8应助科研通管家采纳,获得10
1秒前
1秒前
Ava应助科研通管家采纳,获得30
1秒前
小马甲应助科研通管家采纳,获得10
1秒前
NexusExplorer应助Wone3采纳,获得10
2秒前
2秒前
悦耳芹菜完成签到,获得积分10
2秒前
3秒前
JamesPei应助细腻初雪采纳,获得30
3秒前
4秒前
4秒前
4秒前
4秒前
5秒前
共享精神应助Beansprout采纳,获得10
6秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Emmy Noether's Wonderful Theorem 1200
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
基于非线性光纤环形镜的全保偏锁模激光器研究-上海科技大学 800
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6412084
求助须知:如何正确求助?哪些是违规求助? 8231229
关于积分的说明 17469530
捐赠科研通 5464891
什么是DOI,文献DOI怎么找? 2887479
邀请新用户注册赠送积分活动 1864234
关于科研通互助平台的介绍 1702915